QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
NASDAQ:PSTV

Plus Therapeutics Insider Trades

$1.66
+0.01 (+0.61 %)
(As of 10/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.62
$1.69
50-Day Range
$1.71
$2.14
52-Week Range
$1.59
$5.42
Volume174,493 shs
Average Volume1.09 million shs
Market Capitalization$20.07 million
P/E RatioN/A
Dividend YieldN/A
Beta0.37

Plus Therapeutics (NASDAQ:PSTV) Insider Buying and Selling Activity

1.80% of Plus Therapeutics' shares are owned by company executives, directors and other insiders. Over the past twelve months, Plus Therapeutics insiders have purchased shares 7 time(s), totalling $45,261.54. Insiders that have bought shares include Robert P Lenk, Andrew John Hugh Macintyr Sims, Marc H. Hedrick, Marc H Hedrick, and Howard Clowes.
Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter


Plus Therapeutics (NASDAQ PSTV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2021Robert P LenkDirectorBuy7,000$1.86$13,020.0010,000  
7/27/2021Andrew John Hugh Macintyr SimsCFOBuy1,986$2.05$4,071.301,986  
4/30/2021Marc H. HedrickCEOBuy2,183$2.28$4,977.2418,580  
3/4/2021Marc H HedrickCEOBuy2,500$2.50$6,250.0016,397  
3/3/2021Howard ClowesDirectorBuy3,000$2.42$7,260.003,000  
12/10/2020Marc H HedrickCEOBuy2,500$1.99$4,975.0013,867  
11/30/2020Marc H HedrickCEOBuy2,200$2.14$4,708.0011,367  
8/25/2020Robert P LenkDirectorBuy3,000$2.49$7,470.003,000  
8/12/2020Greg PetersenDirectorBuy10,000$2.52$25,200.0010,000  
8/12/2020Marc H HedrickCEOBuy4,000$2.58$10,320.009,167  
6/22/2020Marc H HedrickCEOBuy5,000$2.10$10,500.005,167  
(Data available from 1/1/2013 forward)












Plus Therapeutics (NASDAQ:PSTV) Insider Trade Frequently Asked Questions

Who is on Plus Therapeutics's Insider Roster?

The list of insiders at Plus Therapeutics includes Andrew John Hugh Macintyr Sims, Greg Petersen, Howard Clowes, Marc H Hedrick, and Robert P Lenk.Learn more on PSTV's insiders

What percentage of Plus Therapeutics stock is owned by insiders?

1.80% of Plus Therapeutics stock is owned by insiders. Learn more on PSTV's insider holdings

Which Plus Therapeutics insiders have been buying company stock?

The following insiders have purchased Plus Therapeutics stock in the last 24 months: Andrew John Hugh Macintyr Sims ($4,071.30), Greg Petersen ($25,200.00), Howard Clowes ($7,260.00), Marc H Hedrick ($36,753.00), and Robert P Lenk ($20,490.00).

How much insider buying is happening at Plus Therapeutics?

Insiders have purchased a total of 43,369 Plus Therapeutics shares in the last 24 months for a total of $98,751.54 bought.

This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.